ONCONOX ApS: Financial statements 2021
CVR: 33858965
ONCONOX ApS (CVR 33858965) has filed annual accounts for 2021. In 2021, the company reported a net result of DKK -43,846 compared with DKK -12,598 the year before. Equity amounted to DKK -43,213.
- Profit/Loss
- -43,846 kr.
- Equity
- -43,213 kr.
- Total Assets
- 22,600 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | - | -44 t. | -43 t. | - |
| 2020 | - | - | -13 t. | 633 | - |
| 2019 | - | - | -66 t. | -37 t. | - |
| 2018 | - | 0 | -1 mio. | 29 t. | - |
| 2017 | - | 547 t. | 393 t. | 1.1 mio. | - |
Find more companies like ONCONOX ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
ONCONOX ApS has published its annual report for 2020. The net result was DKK -12,598.
About ONCONOX ApS
ONCONOX ApS was a Danish company of the type Anpartsselskab based in Greve, founded in 2011. The company was registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company is owned by Amme Pharmaceuticals, Inc.. The company has 0 employees. In 2022, the company reported a net result of DKK -40,672 compared with DKK -43,846 the year before. Equity amounted to DKK -4,305.
